---
schema_version: "secwatch.filing_event.v1"
accession: "0000818479-23-000052"
form_type: "8-K"
ticker: "XRAY"
cik: "0000818479"
company_name: "DENTSPLY SIRONA Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T15:43:18.290334+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Dentsply Sirona Q2 organic sales +2.3%, raises FY guidance; discloses material weakness

## Summary
- Q2 net sales $1,028M (+0.5% reported, +2.3% organic); GAAP EPS $0.40, adj. EPS $0.51.
- Raises FY23 net sales midpoint by $75M to $3.98-4.02B; adj. EPS outlook to $1.92-2.02.
- Discloses new material weakness over manual journal entry segregation of duties as of Dec. 31, 2022.
- Prior 10-K and Q1 10-Q internal control reports no longer reliable; financial statements unchanged.
- Effective Q2 2023, reportable segments realigned to four: Connected Tech, Essential Dental, Ortho/Implant, Wellspect.

## SEC filing metadata
- accession: 0000818479-23-000052
- form_type: 8-K
- ticker: XRAY
- cik: 0000818479
- company_name: DENTSPLY SIRONA Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818479/000081847923000052/0000818479-23-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818479/000081847923000052/xray-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000818479-23-000052
- JSON: https://secwatch.observer/filing/0000818479-23-000052.json
- Plain text: https://secwatch.observer/filing/0000818479-23-000052.txt

## Key facts
- Earnings Releases
  DENTSPLY SIRONA Inc. reported second quarter ended June 30, 2023 results: revenue $1,028 million, net income $86 million, EPS $0.40 per diluted share. Guidance raised.
  - Period: second quarter ended June 30, 2023
  - Revenue: $1,028 million
  - Net income: $86 million
  - EPS: $0.40 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: Second quarter net sales of $1,028 million increased 0.5% (organic sales increased 2.3%), compared to $1,023 million in the second quarter of 2022. Net income for the second quarter of 2023 was $86 million, or $0.40 per diluted share, compared to net income of $73 million, or $0.34 per diluted share in the second quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818479/000081847923000052/0000818479-23-000052-index.htm
- Governance Changes
  DENTSPLY SIRONA Inc.: Amended and Restated By-laws to adopt Universal Proxy Rule requirements and conform to recent Delaware law amendments, effective immediately (effective 2023-07-27).
  - Change: bylaw amendment
  - Effective: 2023-07-27
  source text: On July 27, 2023, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) adopted and approved the Seventh Amended and Restated By-laws of the Company (as amended and restated, the “Amended and Restated Bylaws”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818479/000081847923000052/0000818479-23-000052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
